Table of Contents Author Guidelines Submit a Manuscript

Diabetic Retinopathy: Mechanism, Diagnosis, Prevention, and Treatment

Call for Papers

Diabetic retinopathy (DR) is a major leading cause of blindness worldwide. It is characterized by neurovascular injury which is thought to start much earlier than the onset of decreased visual acuity. Improved understanding of the early cellular and molecular mechanisms of this neurovascular injury will depend upon the development of experimental animal models and novel approaches to characterize these clinical conditions. New advances in this field will provide better care to patients at an earlier stage prior to vision deterioration.

We invite investigators to contribute original research articles as well as review articles that will further our understanding of the molecular pathology underlying retinal neurovascular injury associated with DR and the development of strategies to diagnose and treat this condition. Potential topics include, but are not limited to:

  • Role of inflammation in the neurovascular injury during DR
  • Stem cells as potential therapy for DR
  • Latest technologies for clinical evaluation, such as new imaging tools
  • Biomarkers in DR
  • Recent advances in ocular drug delivery
  • Study models of diabetic retinopathy
  • Novel therapeutic strategies/mechanisms

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:

Manuscript DueFriday, 15 August 2014
First Round of ReviewsFriday, 7 November 2014
Publication DateFriday, 2 January 2015

Lead Guest Editor

  • Mohamed Al-Shabrawey, Department of Oral Biology and Anatomy and Ophthalmology, College of Dental Medicine and Medical College of Georgia, Georgia Regents University, Augusta, GA, USA

Guest Editors

  • Wenbo Zhang, Department of Ophthalmology and Visual Sciences, The University of Texas Medical Branch at Galveston, Galveston, TX, USA
  • Denise McDonald, Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Institute of Clinical Sciences, Belfast, UK